Enhancement of Peptide Vaccine Immunogenicity by Increasing Lymphatic Drainage and Boosting Serum Stability
Antitumor T-cell responses have the potential to be curative in cancer patients, but the induction of potent T-cell immunity through vaccination remains a largely unmet goal of immunotherapy. We previously reported that the immunogenicity of peptide vaccines could be increased by maximizing delivery...
Main Authors: | Karver, Mark R., Dinter, Jens, Gall, Sylvie Le, Moynihan, Kelly Dare, Holden, Rebecca Lynn, Mehta, Naveen, Wang, Chensu, Liang, Simon, Abraham, Wuhbet, Melo, Mariane Bandeira, Zhang, Angela Q., Li, Na, Pentelute, Bradley L., Irvine, Darrell J |
---|---|
Other Authors: | Harvard University--MIT Division of Health Sciences and Technology |
Format: | Article |
Published: |
American Association for Cancer Research
2018
|
Online Access: | http://hdl.handle.net/1721.1/117745 https://orcid.org/0000-0001-5286-4060 https://orcid.org/0000-0003-3480-6750 https://orcid.org/0000-0003-2599-2774 |
Similar Items
-
Nanoparticulate STING agonists are potent lymph node–targeted vaccine adjuvants
by: Crespo, Monica P., et al.
Published: (2015) -
Immunogenicity of RNA Replicons Encoding HIV Env Immunogens Designed for Self-Assembly into Nanoparticles
by: Melo, Mariane Bandeira, et al.
Published: (2021) -
Engineering New Approaches to Cancer Vaccines
by: Irvine, D. J., et al.
Published: (2017) -
Cell-penetrating peptides enhance peptide vaccine accumulation and persistence in lymph nodes to drive immunogenicity
by: Backlund, Coralie M, et al.
Published: (2023) -
Roles for Innate Immunity in Combination Immunotherapies
by: Moynihan, Kelly Dare, et al.
Published: (2018)